Deglycosylated Ricin A Chain-Conjugated Anti-CD19/Anti-CD22 Immunotoxins

A combination preparation of 1:1 mixture of two immunotoxins, HD37-dgA and RFB4-dgA, with potential antineoplastic activity. Both anti-CD19 IgG monoclonal antibody HD37 and anti-CD22 IgG monoclonal antibody RFB4 are attached to a single deglycosylated ricin A chain (dgA) via N-succinimidyl-oxycarbonyl-alpha-methyl-alpha-(2-pyridyldithio) toluene (SMPT) linker. CD19 and CD22 molecules are cell suface antigens present on the majority of B acute lymphoblastic leukemia cells. This combination agent is able to specifically recognize and bind to CD19 and CD22 expressing tumor cells, thereby targeting the delivery of the cytotoxic ricin A chain to leukemia cells expressing these antigens. Ricin A chain is toxic to ribosomal activity and protein synthesis, and inhibits cell growth. (NCI Thesaurus)

YOU MAY ALSO LIKE

Degenerative Nerve Diseases

Degenerative nerve diseases affect many of your body's activities, such as balance, movement, talking, breathing, and heart function. Many of…

Degenerative Disorder

A disorder characterized by the progressive loss of function and/or structure of the affected tissues.

Degenerative disease

A disease in which the function or structure of the affected tissues or organs changes for the worse over time. Osteoarthritis, osteoporosis,…

Degeneration

The process of declining from a higher to a lower level of effective power or vitality or essential quality.

Degenerated Leukocyte Count

The determination of the amount of degenerated leukocytes (leukocytes that show deterioration in form or function) present in a sample.

Degarelix Acetate

The acetate form of a long-acting, synthetic peptide with gonadotrophin-releasing hormone (GnRH) antagonistic properties. Degarelix targets and blocks GnRH receptors located on…